These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23781283)

  • 21. Near-Infrared Photoimmunotherapy Targeting Prostate Cancer with Prostate-Specific Membrane Antigen (PSMA) Antibody.
    Nagaya T; Nakamura Y; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Kobayashi H
    Mol Cancer Res; 2017 Sep; 15(9):1153-1162. PubMed ID: 28588059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Near-infrared photoimmunotherapy (NIR-PIT) on cholangiocarcinoma using a novel catheter device with light emitting diodes.
    Hirata H; Kuwatani M; Nakajima K; Kodama Y; Yoshikawa Y; Ogawa M; Sakamoto N
    Cancer Sci; 2021 Feb; 112(2):828-838. PubMed ID: 33345417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases.
    Inagaki FF; Wakiyama H; Furusawa A; Okada R; Kato T; Fujimura D; Okuyama S; Fukushima H; Takao S; Choyke PL; Kobayashi H
    Biomed Pharmacother; 2023 Apr; 160():114390. PubMed ID: 36791566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms.
    Ito K; Mitsunaga M; Arihiro S; Saruta M; Matsuoka M; Kobayashi H; Tajiri H
    BMC Cancer; 2016 Jan; 16():37. PubMed ID: 26810644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective Photokilling of Colorectal Tumors by Near-Infrared Photoimmunotherapy with a GPA33-Targeted Single-Chain Antibody Variable Fragment Conjugate.
    Wei D; Tao Z; Shi Q; Wang L; Liu L; She T; Yi Q; Wen X; Liu L; Li S; Yang H; Jiang X
    Mol Pharm; 2020 Jul; 17(7):2508-2517. PubMed ID: 32396000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging.
    Nakajima T; Sano K; Mitsunaga M; Choyke PL; Kobayashi H
    Cancer Res; 2012 Sep; 72(18):4622-8. PubMed ID: 22800710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trastuzumab-based near-infrared photoimmunotherapy in xenograft mouse of breast cancer.
    Yamashita S; Kojima M; Onda N; Yoshida T; Shibutani M
    Cancer Med; 2023 Feb; 12(4):4579-4589. PubMed ID: 36259134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of conjugate and light dose on photo-immunotherapy induced cytotoxicity.
    Nakajima T; Sato K; Hanaoka H; Watanabe R; Harada T; Choyke PL; Kobayashi H
    BMC Cancer; 2014 May; 14():389. PubMed ID: 24885589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Near infrared photoimmunotherapy of B-cell lymphoma.
    Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H
    Mol Oncol; 2016 Nov; 10(9):1404-1414. PubMed ID: 27511870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic fluorescent imaging with indocyanine green for monitoring the therapeutic effects of photoimmunotherapy.
    Ali T; Nakajima T; Sano K; Sato K; Choyke PL; Kobayashi H
    Contrast Media Mol Imaging; 2014; 9(4):276-82. PubMed ID: 24706611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Near infrared photoimmunotherapy with an anti-mesothelin antibody.
    Nagaya T; Nakamura Y; Sato K; Zhang YF; Ni M; Choyke PL; Ho M; Kobayashi H
    Oncotarget; 2016 Apr; 7(17):23361-9. PubMed ID: 26981775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer models.
    Moore LS; de Boer E; Warram JM; Tucker MD; Carroll WR; Korb ML; Brandwein-Gensler MS; van Dam GM; Rosenthal EL
    Cancer Med; 2016 Jul; 5(7):1526-34. PubMed ID: 27167827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate.
    Nagaya T; Gorka AP; Nani RR; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Schnermann MJ; Kobayashi H
    Mol Cancer Ther; 2018 Mar; 17(3):661-670. PubMed ID: 29237807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy.
    Mitsunaga M; Nakajima T; Sano K; Kramer-Marek G; Choyke PL; Kobayashi H
    BMC Cancer; 2012 Aug; 12():345. PubMed ID: 22873679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating near-infrared photoimmunotherapy for targeting fibroblast activation protein-α expressing cells in vitro and in vivo.
    Jin J; Barnett JD; Krishnamachary B; Mironchik Y; Luo CK; Kobayashi H; Bhujwalla ZM
    Cancer Sci; 2023 Jan; 114(1):236-246. PubMed ID: 36169301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The feasibility of Miltuximab®-IRDye700DX-mediated photoimmunotherapy of solid tumors.
    Polikarpov DM; Campbell DH; Lund ME; Lu Y; Lu Y; Wu J; Walsh BJ; Zvyagin AV; Gillatt DA
    Photodiagnosis Photodyn Ther; 2020 Dec; 32():102064. PubMed ID: 33069874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti-CD44-Based NIR-PIT.
    Nagaya T; Nakamura Y; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Allen C; Kobayashi H
    Mol Cancer Res; 2017 Dec; 15(12):1667-1677. PubMed ID: 28923838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination photoimmunotherapy with monoclonal antibodies recognizing different epitopes of human epidermal growth factor receptor 2: an assessment of phototherapeutic effect based on fluorescence molecular imaging.
    Ito K; Mitsunaga M; Nishimura T; Kobayashi H; Tajiri H
    Oncotarget; 2016 Mar; 7(12):14143-52. PubMed ID: 26909859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cadherin-17 Targeted Near-Infrared Photoimmunotherapy for Treatment of Gastrointestinal Cancer.
    Lum YL; Luk JM; Staunton DE; Ng DKP; Fong WP
    Mol Pharm; 2020 Oct; 17(10):3941-3951. PubMed ID: 32931292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models.
    Maruoka Y; Furusawa A; Okada R; Inagaki F; Fujimura D; Wakiyama H; Kato T; Nagaya T; Choyke PL; Kobayashi H
    Cancer Immunol Res; 2020 Mar; 8(3):345-355. PubMed ID: 31953245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.